Insider filing · MLYS
Brian Taylor Slingsby sold $43.4M of Mineralys Therapeutics (MLYS)
Executed Nov 20 2025, disclosed Nov 21 2025, 1 day later.
Value, as filed
$43.4M
1,000,000 sh × $43.35
Executed
Nov 20 2025
the trade date, as filed
Disclosed
Nov 21 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
BS
Brian Taylor Slingsby
Director
profile →
Brian Taylor Slingsby (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $43.4M of MLYS (1,000,000 sh × $43.35, as filed), executed Nov 20 2025.
The name
MLYS
Mineralys Therapeutics, Inc.
MLYS · Healthcare · 50 filings in 24 months
ticker →
Healthcare · Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Brian Taylor Slingsby in MLYS
MLYSPURCHASE
Mineralys Therapeutics, Inc.
$3.5M259,259 sh × $13.50
Exec Mar 13 2025
Filed Apr 25 2025 · 5:30 PM ET †